[New developments in hormonal therapy for breast cancer].
Recently, new hormonal drugs such as aromatase inhibitor, LHRH and analogue and the derivative of tamoxifen have been introduced clinically into treatment of breast cancer. Combined therapies not only with a variety of hormonal drugs but with anti-cancer drugs are under consideration and superior results are expected.
Tominaga
T
T
Dept. of Surgery, Tokyo Metropolitan Komagome Hospital, Japan.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D010052:Ovariectomy; D011960:Receptors, Estrogen / Q000378:metabolism; D013629:Tamoxifen / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D013629:Tamoxifen; D007987:Gonadotropin-Releasing Hormone; D017258:Medroxyprogesterone Acetate